Cargando…
Leucovorin Enhances the Anti-cancer Effect of Bortezomib in Colorectal Cancer Cells
Colorectal cancer is a major cancer type worldwide. 5-fluorouracil, often given with leucovorin, is the most commonly used drug in colorectal cancer chemotherapy, yet development of drug resistance to 5-fluorouracil in colorectal cancer cells is the primary cause of chemotherapy failure. Most patien...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429730/ https://www.ncbi.nlm.nih.gov/pubmed/28386133 http://dx.doi.org/10.1038/s41598-017-00839-9 |